Inseego Unveils the Ultimate 5G Industrial Gateway
22.7.2021 15:30:00 EEST | Business Wire | Press release
Inseego Corp. (NASDAQ: INSG), a leader in 5G device-to-cloud solutions, today introduced its Wavemaker PRO 2000e industrial gateway. Combining high-performance 5G with the most advanced 4G LTE capabilities, this solution delivers best-in-class throughput and reliability for industrial IoT and enterprise networks.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210722005327/en/
(C)2021. Inseego Corp. All rights reserved. 5G industrial gateway S2000e.
“We designed the S2000e to provide the best possible 5G connection for any routing system or endpoint, with maximum speed, reliability and security,” said Inseego President Ashish Sharma. “It brings multi-gigabit performance to both on-premise and remote installations for industrial IoT networks, private networks, SD-WANs and other business networks.”
With enterprise-grade hardware features, cloud-based remote device management and advanced security capabilities, the S2000e is designed to ensure 24/7 business continuity and safeguard critical connections.
“The intersection of mobile, cloud and edge compute technology is driving a new era in 5G LAN innovation,” said Ozer Dondurmacıoğlu, VP of Marketing at Celona. “With its new S2000e gateway that supports advances such as concurrent 4G/5G carrier aggregation, Inseego is leading this charge delivering the high-performance connectivity, resilience and versatility that have become non-negotiable for enterprises actively building their own private cellular networks.”
In addition to supporting fixed installations, the S2000e is ideal for mobile installations, providing 5G/LTE and GPS for vehicular area networks. One great example is Shoreline Sightseeing, which operates the largest fleet of water taxis and tour boats in Chicago.
“The results we’ve seen on our vessels with the Wavemaker PRO S2000e have been outstanding,” said Ken Wagner, IT Manager for Shoreline Sightseeing. “We’re using these 5G gateways to provide WAN backhaul (cellular to ethernet) for the network routing systems on our boats, which connect our onboard POS systems and live streaming video feeds, and allow us to remotely retrieve video data from onboard DVRs. The speed and reliability we’re seeing from the S2000e is far better than any of the products we’ve used in the past.”
Continuous, multi-gigabit 5G connectivity
The S2000e is the only commercially available 5G industrial gateway with simultaneous 4x4 MIMO LTE and 5G connectivity, enabling faster throughput* and better coverage at all times, even when falling back to LTE.
It also provides a higher thermal threshold than other gateways. Advanced thermal management enables the S2000e to provide multi-gigabit 5G data rates continuously, without throttling the available sub-6 bandwidth or falling back to LTE due to internal temperatures. This is especially important for industrial environments with extreme temperatures, including installations where the S2000e is in a factory environment or inside an enclosure or cabinet.
The S2000e is available now and supports sub-6 GHz 5G and LTE (Cat 22). In addition, mmWave units are available for proof-of-concept for indoor mmWave use cases.
Downtime prevention
Mission-critical and business-critical networks can’t afford a minute of downtime. The S2000e features dual SIMs for both primary and backup connectivity with auto-switching for instantaneous failover. Active keepalive also monitors the WAN connection to ensure the device is always ready to pass traffic.
Maximum deployment flexibility
With 6 antenna ports and multiple antenna accessories, the S2000e can provide a strong signal almost anywhere. Users can attach dipole antennas for in-building coverage or pipe antennas outside of a building or enclosure for an even better signal. The 6 cellular antennas also allow the device to dedicate four ports to 4x4 MIMO and the other ports to 5G, making it the only device on the market capable of doing so.
It connects to any routing system or remote endpoint through its 5 Gb ethernet port or its 2.7 Gb USB-C port using DHCP (router mode or IPPT modem mode).
Support for PoE PD means the S2000e can be powered by another PoE device (routing system or PoE injector) so you can locate it almost anywhere.
A variety of mounting brackets enable installation on a desk, wall, pole, DIN rail or strut framing.
The Inseego mobile app also simplifies self-installation, from identifying the best location to setup, startup and more.
Device-to-cloud software for remote management and advanced security
The Wavemaker PRO 5G S2000e supports Inseego Connect™ device management for remote configuration, visibility and control of all deployed devices through a single console, helping to avoid data overage charges, ensure device health and more.
In addition to many built-in security features, Inseego Secure cloud-based software (available in Q3) provides active threat detection and alerts of any device-related anomalies.
Wavemaker PRO software offers quarterly feature enhancements and security updates over FOTA** to future-proof the S2000e, increasing its lifetime value.
Purpose-built for the most demanding applications
The S2000e is ideal for industrial and enterprise use cases such as:
- Manufacturing Equipment – Supports real-time monitoring and control systems in factories and other facilities, with high throughput, low latency and fewer wiring hassles.
- Energy & Utility Enclosures – Ideal for remote installations where wireline won’t work, including remote pump stations, meter readers, and more. High security and reliability for critical infrastructure.
- Remote Surveillance Enclosures – Supports multiple 4K video streams and provides the ability to leverage less congested parts of the network.
- State & Local Government WAN Connection – A great alternative to wireline for large offices and remote sites, the S2000e provides high-throughput backhaul for routing systems and access points.
- Education WAN Connection – Transmit live video streams from one teacher to multiple classrooms or distance learning locations using the S2000e for backhaul to the cellular network.
"The nexus of 5G and industrial IoT will change the way critical assets and infrastructure are managed, controlled and secured,” said Dan Shey, Managing Director and Vice President at ABI Research. “A go-anywhere enterprise-grade 5G gateway that can deliver continuous high throughput will be a must-have for many of these deployments.”
Trusted and secure
Designed and developed in the U.S., Inseego solutions are trusted by leading mobile operators, government agencies and enterprise customers worldwide.
Availability
The Wavemaker PRO 5G industrial gateway S2000e is now commercially available from Inseego.
The S2000e is certified for use on North American (FCC/PTCRB) and European (CE) private networks, and leading carrier networks in the U.S. (including Verizon and T-Mobile), and is available for general carrier approval in EU/UK (GCF) and AU/NZ (RCM/RSM).
To learn more about Inseego 5G products and solutions go to inseego.com. For press and analyst inquiries, please email press@inseego.com.
About Inseego Corp.
Inseego Corp. (Nasdaq: INSG) is an industry leader in smart device-to-cloud solutions that extend the 5G network edge, enabling broader 5G coverage, multi-gigabit data speeds, low latency and strong security to deliver highly reliable internet access. Our innovative mobile broadband, fixed wireless access (FWA) solutions and software platform incorporate the most advanced technologies (including 5G, 4G LTE, Wi-Fi 6 and others) into a wide range of products that provide robust connectivity indoors, outdoors and in the harshest industrial environments. Designed and developed in the USA, Inseego products and SaaS solutions build on the company’s patented technologies to provide the highest quality wireless connectivity for service providers, enterprises and government entities worldwide. www.inseego.com #Putting5GtoWork
__________________
*Actual speeds experienced are dependent on carrier network and coverage.
**FOTA opt-out is available.
©2021 Inseego Corp. All rights reserved. The Inseego name and logo are registered trademarks, and the Inseego Wavemaker and Inseego Connect names are trademarks of Inseego Corp. Other Company, product or service names mentioned herein are the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210722005327/en/
Contact information
Inseego Media contact:
Anette Gaven
Tel: +1 (619) 993-3058
Anette.Gaven@inseego.com
Investor Relations contact:
Joo-Hun Kim, MKR Group
Tel: +1 (212) 868-6760
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom